The partnership between Lipogems and the Crohn's & Colitis Foundation marks a significant step in advancing treatment options for IBD patients. By leveraging the Lipogems system, which utilizes patients' own Microfat to heal tissue, this collaboration has the potential to significantly improve patient outcomes and reduce the need for invasive procedures. The commitment from both organizations to raise awareness and educate clinicians and patients is commendable, and it is anticipated that this initiative will pave the way for broader acceptance and application of innovative adipose tissue solutions in the medical community.